Effects of bradykinin on NIH 3T3 fibroblasts pretreated with lithium Mimicking events of Ha-ras oncogene expression by Ritter, Markus et al.
 .Biochimica et Biophysica Acta 1358 1997 23–30
Effects of bradykinin on NIH 3T3 fibroblasts pretreated with lithium
Mimicking events of Ha-ras oncogene expression
Markus Ritter a,), Peter Dartsch b, Siegfried Waldegger b, Thomas Haller c, Heinz Zwierzina a,
Hans Joachim Lang d, Florian Lang b
a Department of Internal Medicine, Uni˝ersity of Innsbruck, Anichstrasse 35, A 6010 Innsbruck, Austria
b Institute of Physiology, Uni˝ersity of Tubingen, Tubingen, FRG¨ ¨
c Institute of Physiology, Uni˝ersity of Innsbruck, Innsbruck, Austria
d Hoechst A.G., Frankfurt, Frankfurt, FRG
Received 3 December 1996; revised 18 March 1997; accepted 18 March 1997
Abstract
 .As shown previously, expression of Ha-ras oncogene in NIH 3T3 fibroblasts qras cells increases cellular concentra-
 .  . 2q w xtions of Ins 1,4,5 P and Ins 1,3,4,5 P and enhances bradykinin induced Ca entry 1–3 . These cells respond to low3 4
concentrations of serum or bradykinin with sustained oscillations of the cell membrane potential due to pulsatile release of
q w xcalcium from internal stores and subsequent activation of calcium sensitive K channels 1 . Furthermore Ha-ras oncogene
w xexpression leads to depolymerization of the actin filament network and delayed increase of cell volume 4–6 . Pretreatment
 . q  .  . w xof the same cells not expressing the oncogene yras cells with Li similarly increases Ins 1,4,5 P and Ins 1,3,4,5 P 2 .3 4
As shown in the present study, yras cells pretreated with Liq similar to Ha-ras oncogene expressing cells respond to
bradykinin with sustained oscillations of cell membrane potential, depolymerization of the actin filament network and
increase of cell volume. The oscillations of the cell membrane potential and the depolymerization of the actin cytoskeleton
can be inhibited by the calcium channel blocker lanthanum and the bradykinin induced increase of cell volume is inhibited
by HOE 694, pointing to involvement of NaqrHq exchange. The data indicate a close functional linkage of the calcium
oscillations, cytoskeletal rearrangement and activation of the NaqrHq exchanger. Thus, Liq pretreatment mimicks crucial
cellular events triggered by expression of the Ha-ras oncogene. However, unlike in cells expressing the Ha-ras oncogene,
Liq pretreatment alone does not allow for growth factor-independent proliferation of the cells.
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1. Introduction
In contrast to normal NIH 3T3 fibroblasts yras
.  .cells , Ha-ras oncogene expressing cells qras cells
respond to bradykinin, bombesin or serum with sus-
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tained oscillations of cell membrane potential due to
2q  .oscillations of intracellular Ca activity Ca andi
subsequent activation of Ca2q sensitive Kq channels
w x 2q7,8 . The Ca oscillations are due to pulsatory
release of Ca2q from intracellular stores triggered by
2q w xCa entry across the cell membrane 1 . Calcium
channel blockers like nifedipine or bepridil inhibit
stimulated calcium entry and oscillations of the cell
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membrane potential and intracellular calcium as well
w xas growth factor independent cell proliferation 8 .
Expression of Ha-ras oncogene in these cells has
been shown to enhance cellular formation of
 .  . w x 2qIns 1,4,5 P and Ins 1,3,4,5 P 1,2 . The altered Ca3 4
metabolism of qras cells may at least partially be
due to the increased levels of these inositolphos-
w xphates 9–11 . Further cellular events observed in
cells expressing the Ha-ras oncogene include marked
cytoskeletal rearrangement due to depolymerization
w xof the actin stress fiber network 3,12,13 and an
increase in cell volume due to activation of NaqrHq
q q y w xexchange and Na , K , 2Cl cotransport 14–17 .
Inhibition of the Ca2q oscillations has been shown to
prevent reorganization of the cytoskeleton, activation
of the NaqrHq exchanger and cell volume increase
w x3,6 . These results point to a central role of Ca ini
the course of malignant transformation during expres-
sion of the Ha-ras oncogene.
Since Liq, which is known to inhibit inositolphos-
phatases, is similarly effective in enhancing cellular
 .  .concentrations of Ins 1,4,5 P and Ins 1,3,4,5 P in3 4
w xthese cells 2,18–20 , it may be expected to mimick
some of the effects of Ha-ras oncogene expression.
The aim of the present study was to test for the effect
of bradykinin on NIH 3T3 fibroblasts pretreated with
Liq to gain a more precise picture of the interrela-
tions between calcium oscillations, cytoskeletal rear-
rangement and altered cell volume regulation in cells
expressing the Ha-ras oncogene. Liq pretreated yras
cells indeed respond to bradykinin with oscillations
of cell membrane potential, depolymerization of the
actin filament network and increase in cell volume,
thus mimicking cellular events necessary for growth
factor independent proliferation observed upon Ha-
ras oncogene expression. However, Liq pretreatment
alone is not sufficient to induce growth factor inde-
pendent cell proliferation.
2. Materials and methods
2.1. Cell culture
The experiments were performed with NIH 3T3
fibroblasts transfected with a transforming Ha-ras
mouse mammary tumor virus long terminal repeat
 .MMTV-LTR construct expressing the Ha-ras
oncogene, which is point-mutated at position 12, after
24 h treatment with 1 mmolrl dexamethasone qras
. w xcells 21 . Transfected cells not treated with dexa-
 .methasone served as controls yras cells . The in-
crease of the expressed protein was routinely con-
w xtrolled by Western blot analysis 4 .
Cells were grown on glass cover slips in Dul-
 .becco’s modified Eagle’s medium DMEM supple-
mented with 10 grl fetal calf serum and 500 mgrml
 .geneticin G-418 sulphate in a moist atmosphere of
378C gassed with 5% CO and 95% air. Prior to the2
experiments the cells were growth arrested by expo-
 .sure to a low-serum medium 0.1–0.5 grl FCS for
24 h. All cell culture reagents were purchased from
Gibco BRL, Eggenstein, FRG. Subcultures were rou-
tinely established on every second to third day of
cultivation by trypsinrEDTA treatment 0.05%; pH
.7.2 .
2.2. Examination of proliferati˝e acti˝ity and cell
˝olume
For the examination of proliferative activity and
analysis of cell volume, yras cells were seeded into
6-well plates Costar 3406; Tecnomara, Fernwald,
. 2FRG at a density of 10 000 cellsrcm using 10 grl
fetal calf serum. Expression of the Ha-ras oncogene
in serum starved cells was achieved by treatment
with 1 mmolrl dexamethasone for 24 h and pretreat-
q ment with Li was achieved by addition of LiCl 10
.mmolrl for the same period. Cells treated with 10
mmolrl NaCl but not stimulated with dexamethasone
served as corresponding controls. Cell numbers were
assesed by counting the cells in defined areas imme-
diately before and 24 h after treatment with dexa-
methasone or Liq. In one series bradykinin was
added twice in a 12-h interval at concentrations of 1
mmolrl.
Cell volume measurements were made using a cell
analysis system Casy TT, Scharfe Instruments, Reut-¨
.lingen, FRG . Prior to the measurements the cells
were dispersed by gentle treatment with calcium- and
magnesium free trypsinrEGTA containing balanced
salt solution and resuspended in the same isotonic
electrolyte solution as described above. During the
measurements cells were kept at 34–378C. The medi-
ans of the cell volume were calculated from the cell
size distribution curves. Absolute cell volumes were
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obtained using various latex beads with diameters
ranging from 6.4 mm to 25.7 mm standard dow
.latex, Serva, Heidelberg, FRG as standards. Where
indicated cells were treated with bradykinin for 1, 5
or 10 min prior to the preparation procedure de-
scribed above.
2.3. Visualization of cytoskeletal elements
For the visualization of cytoskeletal elements, cells
were cultivated on glass cover slips 17 mm in
. diameter in 12-well plates Costar 3512; Tecnomara,
.Fernwald, FRG as described above. Cells were fixed
in 3.5 grl formaldehyde in phosphate-buffered saline
for 15 min at room temperature and permeabilized in
1 grl Triton X-100 in phosphate-buffered saline for 2
min at room temperature. Actin-containing stress
fibers were stained with 2 mgrl TRITC-phalloidin
 .Sigma Chemie, Deisenhofen, FRG , a specific probe
w xfor F-actin 22 10 min at room temperature in the
w xdark 23,24 . All samples were mounted in Mowiol
 .4-88 Hoechst, Frankfurt, FRG and examined and
photographed with a Nikon Optiphot microscope
 .Nikon, Dusseldorf, FRG equipped for epifluo-¨
rescence with the appropriate filter sets using a Nikon
Planapo 40r1.0 oil or 60r1.4 oil lens. Micrographs
were taken with a Nikon UFX-II-35 mm equipment
on Kodak Trix-X pan film at 1600 ASA rating.
2.4. Electrophysiology
For determination of cell membrane potential, glass
cover slips with incompletely confluent cell layers
were mounted into a perfusion chamber volume: 0.1
.ml, perfusion rate 12 mlrmin . Measurements of the
 .potential difference across the cell membrane PD
were made using conventional microelectrodes tip
diameter -0.5 mm, input resistance 100–200 MV ,
.tip potential -5 mV , back filled with 1 molrl KCl,
versus an AgrAgCl electrode connected to the bath
via a 3 molrl KCl-agar bridge. Impalements were
made under an inverted phase-contrast microscope
 .Invertoscop ID, Zeiss, Oberkochen, FRG , using a
piezostepper PM 20 N, Frankenberger, Germering,
. FRG mounted on a Leitz micromanipulator Leitz,
.Wetzlar, FRG . To determine the input resistance
before, during and after impalement square wave
pulses up to 50 pA were injected by a stimulator
 .Grass Instr., Quincy, MA, USA and the voltage
deflection was used to calculate the input resistance,
which had to be similar before and after the impale-
ment. Measurements of the cell membrane potential
were recorded on a chart recorder BBC, Vienna,
.Austria .
2.5. Solutions and chemicals
The experiments were performed at 34–378C. The
extracellular superfusate was composed of all num-
.bers mmolrl : 114 NaCl, 5.4 KCl, 0.8 MgCl , 1.22
CaCl , 0.8 Na HPO , 0.2 NaH PO , 20 NaHCO2 2 4 2 4 3
and 5.5 glucose. Where indicated 10 mmolrl LiCl
were added at the expense of NaCl. The solutions
were equilibrated with 5% carbon dioxide and 95%
 . air pH 7.4 . In solutions containing LaCl 13
.mmolrl NaHCO and Na HPO rNaH PO were3 2 4 2 4
removed, NaCl was reduced to 110 mmolrl and 20
 .mmolrl HEPES-NaOH was added pH 7.4 . Where
 .indicated, bradykinin 0.1 or 1 mmolrl andror HOE
 . q q694 10 mmolrl , a blocker of the Na rH ex-
w xchanger 12 , was added. HOE 694 was from Hoechst,
Frankfurt. All other chemicals were from Sigma,
Munich, FRG.
2.6. Statistics
Applicable data are expressed as arithmetic means
 ."standard error of the mean S.E.M. . Statistical
analysis was made by paired or unpaired t-test, where
applicable. Statistically significant differences were
assumed at P-0.05.
3. Results
As shown in Fig. 1a, bradykinin led to a transient
hyperpolarization of the cell membrane potential of
untreated NIH 3T3 fibroblasts, but led to sustained
oscillations of cell membrane potential in cells pre-
q treated with 10 mmolrl Li for 24 h amplitudes
.y15"4 mV, ns4; Fig. 1b . The oscillations were
identical in frequency and amplitude to the oscilla-
tions elicited by bradykinin in Ha-ras oncogene ex-
w xpressing cells 7,25 . Similar to the oscillations in
Ha-ras oncogene expressing cells, the oscillations in
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Liq treated cells were inhibited by 1 mmolrl lan-
w x  .thanum 8,25 insert in Fig. 1b .
Abundant actin containing stress fibers were ob-
q  .served in both Li treated 80"20%, ns4 and
untreated cells 85"10%, ns4; Fig. 1c and Fig.
.2a . This observation contrasts the cytoskeleton of
 .  .Fig. 1. A. Effect of bradykinin 0.1 mmolrl on the cell membrane potential of untreated NIH 3T3 fibroblasts original tracing . B.
q  .Bradykinin induced oscillations of the cell membrane potential of NIH 3T3 fibroblasts pretreated with Li original tracing . Insert:
 .  .Amplitude in mV of the oscillations of the cell membrane potential in the absence BRADY and presence of 1 mmolrl lanthanum
 .  .BRADYqLANTHAN; arithmetic mean"S.E.M. . C. Influence of bradykinin 1 mmolrl on actin containing stress fibers in untreated
 . q  .  .cells filled bars and in cells pretreated with Li in the absence hatched bars and presence dotted bar of 1 mmolrl lanthanum
 .  .  .arithmetic mean"S.E.M. . D. Influence of bradykinin 1 mmolrl on cell volume in untreated cells filled bars and in cells pretreated
q  . with Li hatched bars . Insert: Effect of 10 mmolrl HOE 694 on bradykinin induced increase of cell volume arithmetic
.mean"S.E.M. .
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Ha-ras oncogene expressing cells with largely de-
 . w xpolymerized actin filaments Fig. 2d 6 . However,
q exposure of Li treated cells to bradykinin 1
.mmolrl led within 10 min to rapid depolymerization
of actin filaments to short fragments distributed
 .throughout the cytoplasm 14"10%, ns4 , thus
approaching a morphology identical to Ha-ras onco-
 .gene expressing cells Fig. 1c and Fig. 2b . This
effect was completely abolished in the presence of 1
mmolrl lanthanum 87"19%, ns3; Fig. 1c and
.Fig. 2c . Exposure of untreated cells to bradykinin
did not result in appreciable alterations of actin poly-
 .merization 87"11%, ns4; Fig. 1c .
 . qThe cell volume CV of Li treated cells was
 .significantly larger 2338"26 fl, ns10 than the
 .cell volume of untreated cells 2225"16 fl, ns10
but still significantly smaller than the cell volume of
 .qras cells 2432"23 fl, ns10 . Preincubation of
 .  .the cells 24 h or acute treatment 15 min with 10
mmolrl HOE 694 did not significantly alter these
 .values. Addition of bradykinin 1 mmolrl to un-
treated cells led to a transient cell shrinkage DCVs
.y110"47 fl, ns5 but did not significantly mod-
ify cell volume within 10 min DCVsy2"14 fl,
. qns5 . In contrast Li treated cells responded to
bradykinin with a significant increase in cell volume
q  .Fig. 2. Actin filament network in NIH 3T3 fibroblasts not expressing the Ha-ras oncogene but pretreated with Li a–c and the same
 .  .  .  .cells expressing the Ha-ras oncogene d before a and 10 min after b, c addition of 1 mmolrl bradykinin in the absence b and
 .presence c of 1 mmolrl lanthanum.
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.DCVs209"11 fl, ns5 . This effect could be
inhibited by simultaneous administration of 10
 .mmolrl HOE 694 DCVs50"11 fl, ns14 .
yras cells exhibited only minute proliferative ac-
tivity compared to qras cells: within 24 h the cell
 .number of yras cells increased by 23"3% ns19
whereas qras cells increased their cell number by
 . q71"9% ns15 . yras cells pretreated with Li
did behave like untreated cells whether or not they
were stimulated by bradykinin 13"4%, ns12 and
.11"5%, ns12, respectively .
4. Discussion
The present data confirm previous observations
demonstrating that bradykinin elicits sustained oscil-
lations of cell membrane potential in Liq treated cells
virtually identical to those observed in NIH 3T3
w xfibroblasts expressing the Ha-ras oncogene 11 .
These oscillations are due to pulsatile release of Ca2q
from intracellular stores and are triggered by stimu-
2q w xlated entry of Ca from the extracellular space 1 .
Upon inhibition of the Ca2q influx by calcium chan-
nel blockers like nifedipine, bepridil, Cd2q, La3q, or
SK and F 96365, a blocker of receptor operated
calcium channels, the oscillations cease and the
growth factor independent proliferation of ras onco-
w xgene expressing cells is inhibited 1,8 . As shown in
this study the bradykinin induced oscillations of the
cell membrane potential in Liq treated cells similarly
can by blocked by lanthanum and hence require
calcium influx. This supports the view, that the
mechanism leading to generation of the oscillations is
similar in Liq treated cells and Ha-ras oncogene
expressing cells and most likely represents calcium
 .induced calcium release CICR .
In NIH 3T3 fibroblasts Liq has been shown to
 .  .increase cellular Ins 1,4,5 P and Ins 1,3,4,5 P con-3 4
centrations similar to Ha-ras oncogene expression
w x2,18 . The elevated inositolphosphate levels may
contribute to altered Ca2q metabolism observed after
 .expression of the oncogene. Ins 1,3,4,5 P has been4
shown to activate calcium channels in the cell mem-
w xbrane 9,10,26 . In v-Ki-ras-transformed NIH 3T3
fibroblasts cytosolic calcium oscillations induced by
 .bradykinin are maintained by Ins 1,3,4,5 P stimu-4
w xlated calcium influx 27 . However, unlike Ha-ras
oncogene expression, pretreatment of the cells with
Liq does not enhance bradykinin induced Ca2q en-
2q w xtry, as reflected by Mn quenching 2,3 . Accord-
ingly, the elevated levels of the inositolphosphates
observed in Ha-ras oncogene expressing or Liq
treated cells may facilitate the oscillations rather by
sensitizing the intracellular stores for calcium in-
duced calcium release.
Beside their ability to respond to bradykinin with
oscillations of the cell membrane potential cells pre-
treated with Liq mimick additional Ca2q dependent
effects of Ha-ras oncogene expression such as de-
w xpolymerization of the actin filaments 6 and delayed
w xincrease of cell volume 4,15,16 . The Ha-ras in-
duced depolymerization of the actin stress fiber net-
work can be prevented if the expression of the onco-
gene takes place in the continuous presence of cal-
w xcium channel blockers like nifedipine or bepridil 6 .
Since these compounds also inhibit the calcium oscil-
lations it was concluded that the cytoskeletal rear-
rangement is driven by the oscillations of intra-
cellular Ca2q. Accordingly similar alterations of the
actin architecture would be expected if calcium oscil-
lations are initiated by bradykinin in Liq-treated cells.
As shown in this study, this is indeed the case: in
parallel to the onset of the oscillations the number of
stress fiber bearing cells decreases, an effect, that can
be inhibited by lanthanum. In untreated cells
bradykinin is without effect on the cytoskeleton and
leads to cell shrinkage due to activation of Kq and
Cly channels even though the parallel activation of
the NaqrHq exchanger tends to increase cell volume
w x q5,28,29 . In contrast Li treated cells respond to
bradykinin with a rapid increase in cell volume which
is mediated by the NaqrHq exchanger. Obviously
the bradykinin induced oscillations of Ca trigger thei
depolymerization of the actin stress fiber network and
support the increase of cell volume upon stimulation
of the NaqrHq exchanger probably by releasing
mechanical constraints from the cells interior.´
Despite its ability to mimick Ha-ras induced
events Liq pretreatment does not stimulate cell pro-
liferation even in the presence of bradykinin. Re-
cently, Ras GAP has been identified as a binding
protein for 1,3,4,5 InsP which specifically stimulates4
w xthe GAP activity on Ras 30 . Therefore the high
levels of 1,3,4,5 InsP in Liq treated yras cells4
might act to inhibit the activity of the endogenous ras
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proteins thus suppressing mitogenic intracellular sig-
nals, whereas ras oncoproteins are insensitive to inac-
w xtivation by stimulated GAP 31 .
In addition to inactivation of inositol phosphatases
Liq might exert effects by interfering with other
signal transduction pathways. Klein and Melton have
shown that Liq effects embryogenesis by specifically
w xinactivating glycogen synthase kinase-3b 32 . Since
ras activation might also lead to suppression of this
kinase some of the Liq effects might be mediated by
w x qsuch a mechanism 33 . Moreover, Li treatment of
hippocampal cells has been shown to result in down-
regulation of the myristoylated alanine-rich C kinase
 .substrate MARCKS protein which is known to bind
Ca2qrcalmodulin and to crosslink actin filaments
w x34 . Similarly Ha-ras transformed fibroblasts exhibit
w xmarkedly reduced levels of MARCKS 35 . Accord-
ingly the cytoskeletal changes observed might also be
governed by altered MARCKS protein regulation.
In conclusion, pretreatment of NIH 3T3 cells with
Liq mimicks several effects of Ha-ras oncogene
expression that have been shown to be prerequisites
for growth factor independent cell proliferation, such
as bradykinin induced oscillations of intracellular
calcium and cell membrane potential, depolymeriza-
tion of actin filaments and increase of cell volume.
The Ca2q oscillations trigger the changes of the actin
architecture and facilitate cell volume increase medi-
ated by the NaqrHq exchanger. Thus Liq treatment
elicits effects that are required to allow for cell
w xproliferation in growth factor depleted media 8,15
but obviously these effects cannot fully substitute for
the cellular machinery triggered by expression of the
Ha-ras oncogene.
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